Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

Celyad Provides Clinical Update and Strategic Outlook for 2018

Celyad Provides Clinical Update and Strategic Outlook for 2018

Letter to Shareholders - December 2017

Letter to Shareholders - December 2017

Celyad to Present at the 29th Annual Piper Jaffray Healthcare Conference

Celyad to Present at the 29th Annual Piper Jaffray Healthcare Conference

Discover our news

Upcoming events

Discover all events

Press material

Dear Journalists,
Please find here all information background and material for your articles.
For any media request, please refer to the contacts below.
Join our press list
Press kit

Press kit

1.5 Mo

a

Press contacts

Celyad

Nicolas Van Hoecke Director, Investor Relations & Communications

+32 (0)10 39 41 84

LifeSci Advisors

Matt Middleman

NewCap (France)

Nicolas Merigeau, Pierre Laurent

+ 33(0)1 44 71 94 94

Comfi (Belgium)

Gunther De Backer, Sabine Leclercq

+32(0) 2 290 90 91